Grown Rogue International (GRUSF) Share-based Compensation (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Share-based Compensation came in at $154994.0 in Q1 2026, down 89.21% year-on-year from $1.4 million in Q1 2025, and up 100.0% quarter-over-quarter from -$1969.7 billion in Q4 2025.

Grown Rogue International (GRUSF) Share-based Compensation (2009 - 2026) Analysis & Trends

Grown Rogue International's Share-based Compensation history runs 14 years deep, the most recent figure standing at $154994.0 for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 89.21% year-over-year to $154994.0 in Q1 2026; TTM through Mar 2026 was -$157635.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 30.18% from the prior year.
  • Share-based Compensation grew to $154994.0 in Q1 2026 per GRUSF's latest filing, from -$1969.7 billion in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1969.7 billion in Q3 2025 and bottomed at -$1969.7 billion in Q4 2025.
  • The 5-year median for Share-based Compensation is $75874.0 (2023), against an average of -$27.1 billion.
  • Biggest YoY gain for Share-based Compensation was 911452470.55% in 2025; the steepest drop was 419.48% in 2025.
  • Year by year, Share-based Compensation stood at $7499.0 in 2022, then jumped by 3773.73% to $290491.0 in 2023, then sank by 130529579.8% to -$379.2 billion in 2024, then slumped by 419.48% to -$1969.7 billion in 2025, then surged by 100.0% to $154994.0 in 2026.
  • Per Business Quant, the three latest GRUSF Share-based Compensation figures stand at $154994.0 (Q1 2026), -$1969.7 billion (Q4 2025), and $1969.7 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 154,994.00

Historic Data

Download Data
DateValue
Mar 31, 2026 154,994.00
Mar 31, 2026 154,994.00
Dec 31, 2025 -1,969.73 Bn
Dec 31, 2025 -1,969.73 Bn
Sep 30, 2025 1,969.73 Bn
Sep 30, 2025 1,969.73 Bn
Jun 30, 2025 6,433.00
Jun 30, 2025 6,433.00
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 -379.18 Bn
Dec 31, 2024 -379.18 Bn
Sep 30, 2024 216,109.28
Sep 30, 2024 216,109.28
Jun 30, 2024 20,607.93
Jun 30, 2024 20,607.93
Mar 31, 2024 56,185.00
Mar 31, 2024 56,185.00
Oct 31, 2023 290,491.00
Oct 31, 2023 290,491.00